Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach

被引:18
|
作者
Xu, Yongmei [2 ]
Wang, Zhen [3 ]
Liu, Renpeng [2 ]
Bridges, Arlene S. [3 ]
Huang, Xuefei [1 ]
Liu, Jian [2 ]
机构
[1] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA
[2] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Pathol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
antithrombin; FGF; heparan sulfate; oligosaccharides; sulfotransferases; COMPOSITIONAL ANALYSIS; CRYSTAL-STRUCTURE; BINDING SITE; GLYCOSAMINOGLYCANS; DISACCHARIDE; INHIBITION; PROTEINS; DESIGN; CODE;
D O I
10.1093/glycob/cwr109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate (HS) and heparin are highly sulfated polysaccharides exhibiting essential physiological functions. The sulfation patterns determine the functional selectivity for HS and heparin. Chemical synthesis of HS, especially those larger than a hexasaccharide, remains challenging. Enzymatic synthesis of HS has recently gained momentum. Here we describe the divergent assembly of HS heptasaccharides and nonasaccharides from a common hexasaccharide precursor. The hexasaccharide precursor was synthesized via a chemical method. The subsequent elongation, sulfation and epimerization were completed by glycosyltransferases, HS sulfotransferases and epimerase. Using the synthesized heptasaccharides, we discovered that the iduronic acid is critical for binding to fibroblast growth factor-2. We also designed a synthetic path to prepare a nonasaccharide with an antithrombin-binding affinity of 3 nM. Our method demonstrated the feasibility of combining chemical and enzymatic synthesis to prepare structurally defined HS oligosaccharides with desired biological activities.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 50 条
  • [21] Synthesis of heparan sulfate oligosaccharides and glycopeptide
    Huang, Xuefei
    Dulaney, Steven
    Xu, Yongmei
    Yoshida, Keisuke
    Yang, Bo
    Yang, Weizhun
    Liu, Jian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [22] Convergent chemoenzymatic synthesis and biological evaluation of a heparan sulfate proteoglycan syndecan-1 mimetic
    Gao, Jia
    Xu, Yongmei
    Liu, Jian
    Huang, Xuefei
    CHEMICAL COMMUNICATIONS, 2021, 57 (27) : 3407 - 3410
  • [23] Recent Advances in the Synthesis of Heparan Sulfate Oligosaccharides
    Yin, Xiaojuan
    Yan, Jun
    Ji, Shengli
    Wang, Fengshan
    Cao, Hongzhi
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2012, 32 (08) : 1388 - 1400
  • [24] A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides
    Liang, Qun Tao
    Xiao, Mao
    Lin, Jian Hui
    Wei, Zheng
    GLYCOBIOLOGY, 2015, 25 (07) : 714 - 725
  • [25] Toward the chemoenzymatic synthesis of heparan sulfate oligosaccharides: oxidative cleavage of p-nitrophenyl group with ceric ammonium salts
    Cai, Chao
    Li, Lingyun
    Harvey, Cate
    Liu, Jian
    Linhardt, Robert J.
    TETRAHEDRON LETTERS, 2013, 54 (33) : 4471 - 4474
  • [26] Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate
    Xu, Ding
    Arnold, Katelyn
    Liu, Jian
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2018, 50 : 155 - 161
  • [27] An Approach for Separation and Complete Structural Sequencing of Heparin/Heparan Sulfate-like Oligosaccharides
    Huang, Rongrong
    Liu, Jian
    Sharp, Joshua S.
    ANALYTICAL CHEMISTRY, 2013, 85 (12) : 5787 - 5795
  • [28] Development of synthetic heparan sulfate oligosaccharides as antiangiogenic agents
    Jayson, Gordon C.
    Hansen, Steen U.
    Miller, Gavin J.
    Cole, Claire
    Rushton, Graham
    Gardiner, John M.
    Avizienyte, Egle
    CANCER RESEARCH, 2015, 75
  • [29] Modular synthesis of heparan sulfate oligosaccharides for array development
    Boons, Geert-Jan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [30] The development of anti-angiogenic heparan sulfate oligosaccharides
    Jayson, Gordon C.
    Miller, Gavin J.
    Hansen, Steen U.
    Barath, Marek
    Gardiner, John M.
    Avizienyte, Egle
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 1596 - 1600